Therapeutics for cognitive aging.
|Title||Therapeutics for cognitive aging.|
|Publication Type||Journal Article|
|Year of Publication||2010|
|Authors||Shineman, DW, Salthouse TA, Launer LJ, Hof PR, Bartzokis G, Kleiman R, Luine V, Buccafusco JJ, Small GW, Aisen PS, Lowe DA, Fillit HM|
|Journal||Annals of the New York Academy of Sciences|
|Volume||1191 Suppl 1|
|Date Published||2010 Apr|
|Keywords||Aging, Biological Markers, Brain Chemistry, Clinical Trials as Topic, cognition, Cognition Disorders, Comorbidity, Humans, Myelin Sheath, Neurons, Neurosecretory Systems, Risk Factors|
This review summarizes the scientific talks presented at the conference "Therapeutics for Cognitive Aging," hosted by the New York Academy of Sciences and the Alzheimer's Drug Discovery Foundation on May 15, 2009. Attended by scientists from industry and academia, as well as by a number of lay people-approximately 200 in all-the conference specifically tackled the many aspects of developing therapeutic interventions for cognitive impairment. Discussion also focused on how to define cognitive aging and whether it should be considered a treatable, tractable disease.
|Alternate Journal||Ann. N. Y. Acad. Sci.|